These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 14105961

  • 1. [ATTENUATION OF THE TOXIC EFFECT OF EMBICHIN (HN2) WITH A SEROTONIN ANTAGONIST].
    FILD DB, MAIRLES A, DOLENDO ES.
    Vopr Onkol; 1963; 9():65-8. PubMed ID: 14105961
    [No Abstract] [Full Text] [Related]

  • 2. INFLUENCE OF SEROTONIN ANTAGONISTS ON NITROGEN MUSTARD INTOXICATION.
    FIELD JB, DOLENDO EC, MIRELES A, ERSHOFF BH.
    Cancer Res; 1965 Apr; 25():382-6. PubMed ID: 14281104
    [No Abstract] [Full Text] [Related]

  • 3. EFFECT OF A SEROTONIN ANTAGONIST ON RADIATION LETHALITY. ANL-6823.
    FEINSTEIN RN, SEAHOLM JE.
    ANL Rep; 1964 Jan; ():99-101. PubMed ID: 14151663
    [No Abstract] [Full Text] [Related]

  • 4. [PHARMACOLOGICAL CHARACTERISTICS OF A NEW SEROTONIN ANTAGONIST WITH ANALGESIC AND ANTIPHLOGISTIC PROPERTIES].
    CERLETTI A, BERDE B, NEUHOLD K, TAESCHLER M.
    Boll Chim Farm; 1963 Sep; 102():602-15. PubMed ID: 14091340
    [No Abstract] [Full Text] [Related]

  • 5. EFFECT OF A SEROTONIN ANTAGONIST ON RADIATION LETHALITY.
    FEINSTEIN RN, SEAHOLM JE.
    Proc Soc Exp Biol Med; 1963 Oct; 114():247-8. PubMed ID: 14076899
    [No Abstract] [Full Text] [Related]

  • 6. Reversal of nitrogen mustard intoxication by a serotonin antagonist.
    FIELD JB, MIRELES A, DOLENDO EC.
    Proc Soc Exp Biol Med; 1962 Oct; 111():1-3. PubMed ID: 13945054
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. REVERSAL OF NITROGEN MUSTARD INTOXICATION BY ANTI-HISTAMINES.
    FIELD JB, MIRELES A, DOLENDO EC, ERSHOFF BH.
    Proc Soc Exp Biol Med; 1964 Apr; 115():1060-2. PubMed ID: 14166559
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. STUDIES ON ANTITUMOR SUBSTANCES. I. ANTITUMOR EFFECT OF QUINONE DERIVATIVES CONTAINING AN ALKYLATING GROUP.
    HAYASHI S, UEKI H, UEKI Y.
    Gan; 1963 Dec; 54():381-90. PubMed ID: 14099936
    [No Abstract] [Full Text] [Related]

  • 15. IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS.
    JANSSEN PA, NIEMEGEERS CJ, SCHELLEKENS KH.
    Arzneimittelforschung; 1965 Feb; 15():104-17. PubMed ID: 14268414
    [No Abstract] [Full Text] [Related]

  • 16. [ON AN ATTEMPT AT COMPENSATION OF LEUKOTOXIC SIDE-EFFECTS DURING THE USE OF CYTOSTATICS, BY SUBSTANCES FROM THE TISSUE- OR CELLULAR THERAPY GROUP].
    SCHMIDT D.
    Zentralbl Chir; 1964 Mar 28; 89():484-9. PubMed ID: 14185467
    [No Abstract] [Full Text] [Related]

  • 17. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
    Darmani NA, Reeves SL.
    Pharmacol Biochem Behav; 1996 Sep 28; 55(1):1-10. PubMed ID: 8870031
    [Abstract] [Full Text] [Related]

  • 18. AUTOLOGOUS MARROW IN TREATMENT OF NITROGEN MUSTARD-INDUCED MARROW DEPRESSION.
    KAISER GA, HERTER FP, MARKOWITZ AM, EVANS S.
    Surgery; 1963 Aug 28; 54():329-32. PubMed ID: 14054722
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.